Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection

Despite the availability of an effective prophylactic vaccine leading to sterilizing immunity, hepatitis B virus (HBV) is responsible for chronic liver disease in more than 250 million individuals, potentially leading to cirrhosis and hepatocellular carcinoma. Antiviral drugs able to completely supp...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Cerino, Antonella, Mantovani, Stefania, Mele, Dalila, Oliviero, Barbara, Varchetta, Stefania, Mondelli, Mario U.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773823/
https://ncbi.nlm.nih.gov/pubmed/31608071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02290
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares